| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co | Sr VP & Princ. Acctg Officer | Ordinary Shares | 46,635 | $5,432,978 | $116.50 | 05 Jan 2022 | Direct |
| Horizon Therapeutics Public Ltd Co | Sr VP & Princ. Acctg Officer | Restricted Stock Units (RSU) | 0 | 10 Jun 2021 | Direct | ||
| Horizon Therapeutics Public Ltd Co | Sr VP & Princ. Acctg Officer | Stock Option (Right to Buy) | 0 | 01 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Public Ltd Co | 04 Jan 2022 | 6 | -$832,542 | 4 | Sr VP & Princ. Acctg Officer | 06 Jan 2022, 20:02 |
| HZNP | Horizon Therapeutics Public Ltd Co | 01 Dec 2021 | 3 | -$6,714,808 | 4 | Sr VP & Princ. Acctg Officer | 03 Dec 2021, 16:20 |
| HZNP | Horizon Therapeutics Public Ltd Co | 10 Jun 2021 | 3 | -$138,764 | 4 | Sr VP & Princ. Acctg Officer | 11 Jun 2021, 17:00 |